The small molecule dopamine analog (DA) CA140, which binds to Amyloid-β (Aβ), presents new possibilities for the treatment of degenerative brain diseases.
New study reveals dopamine analog CA140 mitigates Alzheimer's disease pathology retrieved 22 August 2024 from https://medicalxpress.com/news/2024-08-reveals-dopamine-analog-ca140-mitigates.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Will EEG be able to read your dreams? The future of the brain activity measure as it marks 100 yearsUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New analysis offers most comprehensive roadmap to date for more targeted Alzheimer's research, drug discoveryFrom studying the human genome to analyzing the way proteins are encoded, or monitoring RNA expression, researchers are rapidly gaining a far richer understanding of the complex genetic and cellular mechanisms that underpin dementia.
Read more »
New brain atlas reveals hidden cell vulnerabilities in Alzheimer'sResearchers created a detailed transcriptomic atlas of six brain regions, revealing cell-type-specific and region-specific vulnerabilities in Alzheimer's disease and highlighting astrocyte genes linked to cognitive resilience.
Read more »
European medicines watchdog rejects new Alzheimer's drugEurope's medicines watchdog on Friday rejected a marketing request for a new Alzheimer's disease treatment, saying the risks of the medicine's side effects, including potential brain bleeding, outweighed the benefits.
Read more »
Blood Tests for Alzheimer’s May Be Coming to Your Doctor’s OfficeNew blood tests could help doctors diagnose Alzheimer’s disease faster and more accurately.
Read more »
New blood test achieves 90% accuracy in diagnosing Alzheimer’s disease, outperforms doctorsResearchers in Sweden developed a combined blood test with up to 90% accuracy for diagnosing Alzheimer's disease, surpassing the diagnostic rates of primary care doctors and specialists.
Read more »
With new technique, patient-derived neurons accurately model late-onset Alzheimer's diseaseResearchers at Washington University School of Medicine in St. Louis have developed a way to capture the effects of aging in the development of Alzheimer's disease.
Read more »